1. Pink Sheet

Fear of Unpredictability: Industry Criticises Japan’s Frequent Pricing Rule Changes

United Call For Reforms

 
• By Lisa Takagi

While Japan enters annual drug price revisions with frequent regulation changes, several major corporate players in the country warn again that government policies mean that the country is at risk of “losing attractiveness.”

Japan's frequent regulation changes
Japan's frequent changes to drug pricing rules provoke discussions • Source: Shutterstock

Pharmaceutical Research and Manufacturers of America (PhRMA), the Japan Pharmaceutical Manufacturers Association (JPMA) and the European Federation of Pharmaceutical Industries and Associations (EFPIA) have made a joint statement for the first time on the need for Japan to improve its policies related to the biopharmaceutical industry.

During a PhRMA press conference in Tokyo held the same day as the 16 May statement, the US group urged the Japanese government to reform its ever-tightening pricing system and review its recent tendency to change associated regulations frequently, describing it as a potential

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Japan

More from Asia